Clinical Trial Update: Changes in Hyperprolactinemia Secondary to Antipsychotics After Switching to Quetiapine

View source ↗

Summary

A completed clinical trial evaluated prolactin changes in patients with antipsychotic-induced hyperprolactinemia after switching to quetiapine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Hyperprolactinemia
• Schizophrenia

Drugs mentioned

• Quetiapine (quetiapine)

Snippet

Sponsor: Investigaciones Médicas Montejo S.L. | Conditions: APS-related Hyperprolactinaemia, Schizophrenia | Status: COMPLETED